Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 12Prostatic Neoplasms 9Neoplasms 9Lung Neoplasms 6Endometrial Neoplasms 6Breast Neoplasms 6Stomach Neoplasms 4Oropharyngeal Neoplasms 4Melanoma 4Colorectal Neoplasms 4Pathologic Complete Response 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Mouth Neoplasms 3Leukemia, Myeloid, Acute 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Rectal Neoplasms 2Meningioma 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leiomyoma 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma, Hepatocellular 2Carcinoma, Basal Cell 2Vaginal Neoplasms 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Trauma, Nervous System 1

Interventions

Radiofrequency Ablation 1Observation 1Adrenalectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hyperaldosteronism × Observation × 1 year × Clear all
NCT07272187 2025-12-09

EURAGIL

Herlev Hospital

Recruiting
138 enrolled
Endocrine

Hyperaldosteronism, Insulinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡